Angiogenesis: from molecular mechanisms to translational implications
- PMID: 23241508
- DOI: 10.3233/CH-121647
Angiogenesis: from molecular mechanisms to translational implications
Abstract
Angiogenesis, the formation and growth of new blood vessels from pre-existing vasculature, is essential for many physiological and pathophysiological processes such as pregnancy, embryonic development, wound healing and tumors. This process is controlled by the balance between pro- and anti-angiogenic signals. The balance can be tilted by the cancer cells, which requires new vessel formation for progression. The stimulatory angiogenic factors such as vascular endothelial growth factor (VEGF) drive vascular growth by attracting and activating cells within the microenvironment of the tumor. Scientists believe that angiogenesis may be a rate-limiting for tumor growth and metastasis. An effective therapy of cancer should involve targeting combinations of angiogenic factors as well as the tumor microenvironment.
Keywords: Angiogenesis; tumor microenvironment.
Similar articles
-
Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.Prog Biophys Mol Biol. 2013 Nov;113(2):333-54. doi: 10.1016/j.pbiomolbio.2013.10.001. Epub 2013 Oct 15. Prog Biophys Mol Biol. 2013. PMID: 24139944 Review.
-
Angiogenesis--a new target for future therapy.Vascul Pharmacol. 2006 May;44(5):265-74. doi: 10.1016/j.vph.2006.01.005. Epub 2006 Mar 20. Vascul Pharmacol. 2006. PMID: 16545987 Review.
-
Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.Mol Aspects Med. 2011 Apr;32(2):71-87. doi: 10.1016/j.mam.2011.04.001. Epub 2011 Apr 22. Mol Aspects Med. 2011. PMID: 21540050 Review.
-
VEGF as a key mediator of angiogenesis in cancer.Oncology. 2005;69 Suppl 3:4-10. doi: 10.1159/000088478. Epub 2005 Nov 21. Oncology. 2005. PMID: 16301830 Review.
-
Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.Curr Opin Genet Dev. 2011 Feb;21(1):73-9. doi: 10.1016/j.gde.2010.10.008. Epub 2010 Nov 22. Curr Opin Genet Dev. 2011. PMID: 21106363 Review.
Cited by
-
Tissue engineering strategies for the induction of angiogenesis using biomaterials.J Biol Eng. 2018 Dec 27;12:36. doi: 10.1186/s13036-018-0133-4. eCollection 2018. J Biol Eng. 2018. PMID: 30603044 Free PMC article. Review.
-
Antiangiogenic effects of oridonin.BMC Complement Altern Med. 2017 Apr 4;17(1):192. doi: 10.1186/s12906-017-1706-3. BMC Complement Altern Med. 2017. PMID: 28376864 Free PMC article.
-
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy.Int J Mol Sci. 2017 Aug 17;18(8):1786. doi: 10.3390/ijms18081786. Int J Mol Sci. 2017. PMID: 28817103 Free PMC article. Review.
-
Characteristics of Inflammatory and Normal Endothelial Exosomes on Endothelial Function and the Development of Hypertension.Inflammation. 2024 Aug;47(4):1156-1169. doi: 10.1007/s10753-024-01967-x. Epub 2024 Jan 19. Inflammation. 2024. PMID: 38240985
-
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies.Drug Saf. 2019 Feb;42(2):159-179. doi: 10.1007/s40264-018-0776-6. Drug Saf. 2019. PMID: 30649744 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
